F. Smets

Epithelial-Mesenchymal Transitions in Development and Disease

Purpose-driven biomaterials research in liver-tissue engineering

CD4 and CD8 T cell responses to tumour-associated Epstein–Barr virus antigens in nasopharyngeal carcinoma patients

An overview of tissue and whole organ decellularization processes

Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix

Recombinant gp350 Vaccine for Infectious Mononucleosis: A Phase 2, Randomized, Double‐Blind, Placebo‐Controlled Trial to Evaluate the Safety, Immunogenicity, and Efficacy of an Epstein‐Barr Virus Vaccine in Healthy Young Adults

3D bioprinting of tissues and organs

Systemic Lupus Erythematosus

Human skin fibroblasts: From mesodermal to hepatocyte-like differentiation

Quantitative EBV Viral Loads and Immunosuppression Alterations can Decrease PTLD Incidence in Pediatric Liver Transplant Recipients

Evolving concepts in liver tissue modeling and implications forin vitrotoxicology

Micropatterned coculture of primary human hepatocytes and supportive cells for the study of hepatotropic pathogens

Infection in Solid-Organ Transplant Recipients

Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures

Defective Control of Latent Epstein-Barr Virus Infection in Systemic Lupus Erythematosus

In situ expansion of engineered human liver tissue in a mouse model of chronic liver disease

Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients

How I treat EBV lymphoproliferation

Priming of protective T cell responses against virus-induced tumors in mice with human immune system components

Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses

Diagnosis and Management of Posttransplant Lymphoproliferative Disorder in Solid‐Organ Transplant Recipients

Hematological Problems in Pediatric Intensive Care

Cellular Responses to Viral Infection in Humans: Lessons from Epstein-Barr Virus

Persistence of a chimerical phenotype after hepatocyte differentiation of human bone marrow mesenchymal stem cells

INDICATIONS AND RESULTS OF CHEMOTHERAPY IN CHILDREN WITH POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE AFTER LIVER TRANSPLANTATION1

Cell transplantation in the treatment of liver diseases

Epstein–Barr virus‐related lymphoproliferation in children after liver transplant: Role of immunity, diagnosis, and management

Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease1